Fatty Acids, Eicosanoids, and Hypolipidemic Agents Identified as Ligands of Peroxisome Proliferator-Activated Receptors by Coactivator-Dependent Receptor Ligand Assay
Grigorios D. Krey, Olivier Braissant, Fabienne L’Horset et al. · Molecular Endocrinology · 1997
Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors controlling the expression of genes involved in lipid homeostasis. PPARs activate gene transcription in response to a variety of compounds including hypolipidemic drugs as well as natural fatty acids. From the plethora of PPAR activators, Scatchard analysis of receptor-ligand interactions has thus far identified only four ligands. These are the chemotactic agent leukotriene B4 and the hypolipidemic drug Wy 14,643 for the alpha-subtype and a prostaglandin J2 metabolite and synthetic antidiabetic thiazolidinediones for the gamma-subtype. Based on the hypothesis that ligand binding to PPAR would induce interactions of the receptor with transcriptional coactivators, we have developed a novel ligand sensor assay, termed coactivator-dependent receptor ligand assay (CARLA). With CARLA we have screened several natural and synthetic candidate ligands and have identified naturally occurring fatty acids and metabolites as well as hypolipidemic drugs as bona fide ligands of the three PPAR subtypes from Xenopus laevis. Our results suggest that PPARs, by their ability to interact with a number of structurally diverse compounds, have acquired unique ligand-binding properties among the superfamily of nuclear receptors that are compatible with their biological activity.
Cited by 1,221 works. doi:10.1210/me.11.6.779 Open-access PDF
Authors
- Grigorios D. Krey
- Olivier Braissant
- Fabienne L’Horset
- Eric Kalkhoven
- Mai Perroud
- Malcolm G. Parker
- Walter Wahli
References
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
- A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors
- Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
- A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
- Adipogenesis and Obesity: Rounding Out the Big Picture
- Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.
- Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
- Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors